Form 4 for LSTA LISATA THERAPEUTICS, INC.

Accepted 2022-01-12 00:00:00 ET · period of report 2022-01-10 · accession 0001879231-22-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-01-12	2022-01-10	LSTA	Buck Kristen K	EVP, CMO, R, D	A - Grant	$0.00	+64.5K	326.9K	+25%	$0
D	2022-01-12	2022-01-10	LSTA	Buck Kristen K	EVP, CMO, R, D	F - Tax	$0.92	-7,694	319.2K	-2%	-$7,078
D	2022-01-12	2022-01-10	LSTA	Buck Kristen K	EVP, CMO, R, D	A - Grant	$0.00	+32.5K	32.5K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-01-10	A	A	64,500	$0.00	326,897	D	—	—	(F1) Represents 64,500 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date. (F2) Includes 257,750 unvested restricted stock.
2	Common	Common Stock	2022-01-10	F	D	7,694	$0.92	319,203	D	—	—	(F3) Shares withheld as payment of a tax liability on vesting of restricted stock. (F2) Includes 257,750 unvested restricted stock.
3	Derivative	Stock Option (Right to Buy)	2022-01-10	A	A	32,500	$0.00	32,500	D	$0.92 · 2022-01-10 to 2032-01-10	32,500 Common Stock	(F4) One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.